Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioTime Inc (NYSE MKT LLC:BTX)

2.95
Delayed Data
As of Aug 27
 +0.12 / +4.24%
Today’s Change
2.20
Today|||52-Week Range
5.95
-20.91%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues1.6M3.9M4.4M5.2M
 
 
 
 
 
Cost of Goods Sold0.00434.3K792.7K837.1K
 
 
 
 
Depreciation And Amortization3.1M2.8M4.0M8.4M
 
 
 
 
 
 
Operating ExpensesGross Income-1.5M647.6K-310.8K-4.0M
 
 
 
 
 
General Expenses20.0M25.6M38.2M46.7M
 
 
 
 
 
Research And Development13.7M16.5M23.3M30.2M
 
 
 
 
 
Total Operating Expenses23.0M28.9M43.0M55.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.5M-25.0M-38.5M-50.7M
 
 
 
 
 
Extraordinary Charge0.00-196.0K-17.5M0.00
 
 
 
Interest Expense On Debt326.000.00--91.0K
 
 
 
Other Expenses3.0M-128.9K-207.1K-383.6K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-18.4M-25.3M-56.2M-51.2M
 
 
 
 
 
Income Taxes0.000.00-3.3M-7.4M
 
 
 
Minority Interest-1.9M-3.9M-9.0M-7.4M
 
 
 
 
 
Preferred Dividend0.000.000.00-86.8K
 
 
Net Income-16.5M-21.4M-43.9M-36.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS47.5M49.2M54.2M66.5M
 
 
 
 
 
Shares To Calculate EPS Diluted47.5M49.2M54.2M66.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.35-$0.44-$0.81-$0.55
 
 
 
 
 
EPS Diluted-$0.35-$0.44-$0.81-$0.55